nevirapine has been researched along with Arteriosclerosis, Coronary in 1 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van der Valk, M | 1 |
| Kastelein, JJ | 1 |
| Murphy, RL | 1 |
| van Leth, F | 1 |
| Katlama, C | 1 |
| Horban, A | 1 |
| Glesby, M | 1 |
| Behrens, G | 1 |
| Clotet, B | 1 |
| Stellato, RK | 1 |
| Molhuizen, HO | 1 |
| Reiss, P | 1 |
1 trial available for nevirapine and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile.
Topics: Adult; Anti-HIV Agents; Coronary Artery Disease; Drug Therapy, Combination; Female; HIV Infections; | 2001 |